Literature DB >> 10738908

Arginase and ornithine, as markers in human non-small cell lung carcinoma.

S Süer Gökmen1, Y Yörük, E Cakir, F Yorulmaz, S Gülen.   

Abstract

The arginase activity and ornithine level were determined in tissue obtained from patients with non-small cell lung carcinoma (NSLC). The arginase activity and ornithine level in tumor tissues were 1.89 +/- 1.28 U/mg protein and 42.32 +/- 25.82 nmol/mg protein, respectively versus 0.67 +/- 0.19 U/mg protein and 10.12 +/- 3.69 nmol/mg protein for normal tissues (p < 0.01).

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10738908

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN： 0305-7232


  10 in total

Review 1.  Metabolic mechanisms of tumor resistance to T cell effector function.

Authors:  Candace M Cham; Thomas F Gajewski
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

Authors:  Athanasios Kotsakis; Malgorzata Harasymczuk; Bastian Schilling; Vasilis Georgoulias; Athanassios Argiris; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2012-04-13       Impact factor: 2.303

Review 3.  Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.

Authors:  Paulo C Rodríguez; Augusto C Ochoa
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

Review 4.  The immunoregulatory mechanisms of carcinoma for its survival and development.

Authors:  Caigan Du; Yuzhuo Wang
Journal:  J Exp Clin Cancer Res       Date:  2011-01-21

5.  Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

Authors:  Paulo C Rodriguez; Claudia P Hernandez; David Quiceno; Steven M Dubinett; Jovanny Zabaleta; Juan B Ochoa; Jill Gilbert; Augusto C Ochoa
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

6.  c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.

Authors:  Yari Ciribilli; Prashant Singh; Alberto Inga; Jürgen Borlak
Journal:  Oncotarget       Date:  2016-10-04

Review 7.  Myeloid Cell-Derived Arginase in Cancer Immune Response.

Authors:  Tomasz M Grzywa; Anna Sosnowska; Paweł Matryba; Zuzanna Rydzynska; Marcin Jasinski; Dominika Nowis; Jakub Golab
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

8.  Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.

Authors:  Malgorzata Czystowska-Kuzmicz; Anna Sosnowska; Dominika Nowis; Kavita Ramji; Marta Szajnik; Justyna Chlebowska-Tuz; Ewa Wolinska; Pawel Gaj; Magdalena Grazul; Zofia Pilch; Abdessamad Zerrouqi; Agnieszka Graczyk-Jarzynka; Karolina Soroczynska; Szczepan Cierniak; Robert Koktysz; Esther Elishaev; Slawomir Gruca; Artur Stefanowicz; Roman Blaszczyk; Bartlomiej Borek; Anna Gzik; Theresa Whiteside; Jakub Golab
Journal:  Nat Commun       Date:  2019-07-05       Impact factor: 14.919

9.  Differential gene-expression profiles associated with gastric adenoma.

Authors:  H Takenawa; M Kurosaki; N Enomoto; Y Miyasaka; N Kanazawa; N Sakamoto; T Ikeda; N Izumi; C Sato; M Watanabe
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

Review 10.  Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook.

Authors:  Lena Horvath; Bernard Thienpont; Liyun Zhao; Dominik Wolf; Andreas Pircher
Journal:  Mol Cancer       Date:  2020-09-11       Impact factor: 27.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.